88 related articles for article (PubMed ID: 6260340)
1. Pharmacokinetics of vincristine in the cerebrospinal fluid of humans.
Jackson DV; Sethi VS; Spurr CL; McWhorter JM
Cancer Res; 1981 Apr; 41(4):1466-8. PubMed ID: 6260340
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates.
Jackson DV; Castle MC; Poplack DG; Bender RA
Cancer Res; 1980 Mar; 40(3):722-4. PubMed ID: 7471091
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of vincristine infusion.
Jackson DV; Sethi VS; Spurr CL; White DR; Richards F; Stuart JJ; Muss HB; Cooper MR; Castle MC
Cancer Treat Rep; 1981; 65(11-12):1043-8. PubMed ID: 7296550
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of vincristine sulfate in adult cancer patients.
Sethi VS; Jackson DV; White DR; Richards F; Stuart JJ; Muss HB; Cooper MR; Spurr CL
Cancer Res; 1981 Sep; 41(9 Pt 1):3551-5. PubMed ID: 7260915
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing: a surrogate marker of brain penetration.
Kellie SJ; Barbaric D; Koopmans P; Earl J; Carr DJ; de Graaf SS
Cancer; 2002 Mar; 94(6):1815-20. PubMed ID: 11920545
[TBL] [Abstract][Full Text] [Related]
8. High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
Tedeschi A; Montillo M; Strocchi E; Cafro AM; Tresoldi E; Intropido L; Nichelatti M; Marbello L; Baratè C; Camaggi CM; Morra E
Cancer Chemother Pharmacol; 2007 May; 59(6):771-9. PubMed ID: 17256136
[TBL] [Abstract][Full Text] [Related]
9. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
Riccardi R; Holcenberg JS; Glaubiger DL; Wood JH; Poplack DG
Cancer Res; 1981 Nov; 41(11 Pt 1):4554-8. PubMed ID: 6895481
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid levels of 2'-deoxycoformycin after systemic administration in monkeys.
Blatt J; Venner PM; Riccardi R; Cohen LF; Gangji D; Glazer RI; Poplack DG
J Natl Cancer Inst; 1982 Mar; 68(3):391-3. PubMed ID: 6977672
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 and blood brain barrier in cats: pharmacokinetics and tolerance following intrathecal and intravenous administration.
Martin R; Schwuléra U; Menke G; Rudolph W; Buch K; Fasold H; Lissner R; Thrun A; Krauseneck P; Bogdahn U
Eur Cytokine Netw; 1992; 3(4):399-406. PubMed ID: 1421012
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
[TBL] [Abstract][Full Text] [Related]
13. CXCL13 and CXCL12 in central nervous system lymphoma patients.
Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of intrathecal chemotherapy and clinical problems].
Fujimoto T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
Kearns CM; Blakley RL; Santana VM; Crom WR
Cancer Res; 1994 Mar; 54(5):1235-9. PubMed ID: 7906999
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal chemotherapy for patients with meningeal carcinomatosis.
Yoshida S; Morii K
Surg Neurol; 2005 Jan; 63(1):52-5; discussion 55. PubMed ID: 15639526
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid polyamines in childhood leukemia.
Smith BJ; Lee S; Sabio H; Wills MR; Savory J
Ann Clin Lab Sci; 1984; 14(3):225-31. PubMed ID: 6587824
[TBL] [Abstract][Full Text] [Related]
18. Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis.
Mehta BM; Glass JP; Shapiro WR
Cancer Res; 1983 Jan; 43(1):435-8. PubMed ID: 6600162
[TBL] [Abstract][Full Text] [Related]
19. Contamination of cerebrospinal fluid specimens with hematogenous blasts in patients with leukemia.
Rohlfing MB; Barton TK; Bigner SH; Johnston WW
Acta Cytol; 1981; 25(6):611-5. PubMed ID: 6947666
[TBL] [Abstract][Full Text] [Related]
20. Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeys.
McGovren JP; Stewart JC; Elfring GL; Smith RB; Soares N; Wood JH; Poplack DG; Von Hoff DD
Cancer Treat Rep; 1982 Jun; 66(6):1333-41. PubMed ID: 7083237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
